Successful treatment of vancomycin-resistant Enterococcus faecium ventriculitis with combined intravenous and intraventricular chloramphenicol in a newborn

J Med Microbiol. 2010 Nov;59(Pt 11):1371-1374. doi: 10.1099/jmm.0.022921-0. Epub 2010 Jul 15.

Abstract

Vancomycin-resistant Enterococcus faecium (VRE) infection is a rare event in paediatric patients and often occurs under immunosuppression or after surgical intervention. We report what we believe to be the first paediatric case of ventriculitis due to VRE (in a 2-month-old infant) to be successfully treated with combined intravenous (i.v.) and intraventricular chloramphenicol after failure of i.v. linezolid and intraventricular gentamicin.

Publication types

  • Case Reports

MeSH terms

  • Acetamides / administration & dosage
  • Anti-Bacterial Agents / administration & dosage*
  • Cerebral Ventricles / microbiology*
  • Cerebral Ventricles / pathology
  • Cerebrospinal Fluid / cytology
  • Cerebrospinal Fluid / microbiology
  • Chloramphenicol / administration & dosage*
  • Encephalitis / diagnosis*
  • Encephalitis / drug therapy
  • Enterococcus faecium / drug effects
  • Enterococcus faecium / isolation & purification*
  • Female
  • Gentamicins / administration & dosage
  • Gram-Positive Bacterial Infections / diagnosis*
  • Gram-Positive Bacterial Infections / drug therapy
  • Head / diagnostic imaging
  • Humans
  • Infant, Newborn
  • Infusions, Intravenous
  • Injections, Intraventricular
  • Linezolid
  • Lumbosacral Region / diagnostic imaging
  • Magnetic Resonance Imaging
  • Oxazolidinones / administration & dosage
  • Pelvis / diagnostic imaging
  • Radiography
  • Treatment Outcome
  • Vancomycin Resistance*

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Gentamicins
  • Oxazolidinones
  • Chloramphenicol
  • Linezolid